| |
| |
|
| Insider
Information: |
Jarrett Jennifer |
| Relationship: |
Former Director |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
310,253 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,105,879 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
310,253 |
|
|
| Total
Value |
$5,105,879 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
14
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
10
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -61.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Medivation Inc |
MDVN |
Chief Financial Officer |
2016-09-28 |
0 |
2016-04-07 |
0 |
Premium* |
|
|
Arena Pharmaceuticals Inc |
ARNA |
Director |
2022-03-11 |
0 |
2018-06-13 |
0 |
Premium* |
|
|
Arcus Biosciences Inc |
RCUS |
Chief Operating Officer |
2024-03-27 |
215,253 |
2020-06-04 |
0 |
Premium* |
|
|
Syndax Pharmaceuticals Inc |
SNDX |
|
2024-02-07 |
65,000 |
2021-02-03 |
0 |
Premium* |
|
|
Surrozen Ord Shs |
SRZN |
Former Director |
2021-08-11 |
30,000 |
2021-08-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
46 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• • – |
2023-01-26 |
4 |
AS |
$23.56 |
$7,068 |
D/D |
(300) |
416,546 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• • – |
2021-06-04 |
4 |
S |
$24.91 |
$26,006 |
D/D |
(1,044) |
119,174 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• • – |
2023-01-27 |
4 |
AS |
$23.52 |
$37,632 |
D/D |
(1,600) |
414,946 |
0 |
% |
|
| ARNA |
Arena Pharmaceuticals Inc |
Director |
– • – |
2020-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,446 |
8,150 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
Director |
– • – |
2019-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,654 |
5,704 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Director |
– • – |
2020-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
103,634 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
Director |
– • – |
2018-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,050 |
3,050 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
Director |
– • – |
2021-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,067 |
11,217 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• • – |
2021-06-16 |
4 |
S |
$24.13 |
$95,850 |
D/D |
(3,968) |
140,206 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• • – |
2021-06-17 |
4 |
S |
$23.68 |
$115,156 |
D/D |
(4,863) |
135,343 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• • – |
2021-12-16 |
4 |
S |
$39.59 |
$221,423 |
D/D |
(5,560) |
132,535 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• • – |
2022-06-16 |
4 |
S |
$20.72 |
$125,998 |
D/D |
(6,081) |
125,233 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• • – |
2022-06-17 |
4 |
S |
$21.71 |
$146,294 |
D/D |
(6,614) |
118,619 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• • – |
2021-12-17 |
4 |
S |
$38.79 |
$287,261 |
D/D |
(7,118) |
125,417 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• • – |
2021-03-16 |
4 |
S |
$35.03 |
$303,394 |
D/D |
(8,661) |
116,973 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• • – |
2023-03-16 |
4 |
S |
$16.81 |
$146,734 |
D/D |
(8,729) |
406,217 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• • – |
2022-03-16 |
4 |
S |
$31.62 |
$304,090 |
D/D |
(9,617) |
105,978 |
0 |
% |
|
| ARNA |
Arena Pharmaceuticals Inc |
Director |
– • – |
2022-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,217) |
0 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• • – |
2023-12-18 |
4 |
D |
$17.74 |
$199,575 |
D/D |
(11,250) |
291,891 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• • – |
2023-12-19 |
4 |
D |
$18.09 |
$207,890 |
D/D |
(11,492) |
280,399 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• – – |
2024-03-27 |
4 |
AS |
$17.55 |
$202,720 |
D/D |
(11,551) |
215,253 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• • – |
2023-06-22 |
4 |
AS |
$19.12 |
$237,795 |
D/D |
(12,437) |
381,566 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• • – |
2023-09-18 |
4 |
D |
$20.40 |
$255,122 |
D/D |
(12,506) |
324,060 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• • – |
2023-06-16 |
4 |
S |
$19.35 |
$243,094 |
D/D |
(12,563) |
394,003 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Operating Officer |
• • – |
2022-09-16 |
4 |
S |
$26.28 |
$333,152 |
D/D |
(12,677) |
130,942 |
0 |
% |
|
46 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
